Atlanta Center for Clinical Research

What Atlanta Center for Clinical Research does

Atlanta Center for Clinical Research (ACCR) is an independent, multi-therapeutic outpatient clinical research site that executes Phase II, Phase III, and Phase IV clinical trials on behalf of pharmaceutical sponsors and contract research organizations. The company operates from a single facility at 11050 Crabapple Road, Building A, Suite 103B, Roswell, Georgia, and is staffed by board-certified physicians, nurses, certified clinical research coordinators, and a dedicated regulatory specialist. ACCR functions as a vendor site within the clinical trial ecosystem: it is awarded studies by sponsors and CROs, recruits and retains qualifying patients, conducts protocol-defined visits, completes case report forms (CRFs), and delivers data outputs against study timelines and regulatory requirements. Its cumulative disclosed track record is approximately 130 studies performed and 1,700 patients enrolled across 15 years of operation.

ACCR generates revenue through project-based fees negotiated on a study-by-study basis with pharmaceutical companies (including Pfizer, Takeda, Amgen, AstraZeneca, and Bayer) and contract research organizations (including Quintiles/IQVIA, PPD, Icon, Parexel, and Covance). Compensation is tied to study execution, patient enrollment, data collection, and regulatory compliance rather than to a subscription, license, or volume-based pricing model. The go-to-market motion is relationship-driven direct enterprise sales, with sponsors placing studies through existing networks and RFP responses rather than through broad marketing or self-service channels. The company does not operate a proprietary technology platform, does not offer software or APIs to sponsors, and does not disclose AI or automation tooling.

The business operates in a single geography (Roswell, Georgia) serving a domestic U.S. patient population within the defined catchment area, and accepts trial placements for multiple therapeutic areas rather than specializing in a single indication. ACCR is privately held with no parent company, no institutional investors, and no disclosed capital raises. Headcount is reported in the 11-50 range, consistent with a single-site operation. The company's stated points of differentiation are timely sponsor response, quality data, high retention rates, dedicated coordinators, and professionally developed standard operating procedures (SOPs).

Name

Atlanta Center for Clinical Research

Legal name

Atlanta Center for Clinical Research

Website

https://atlccr.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Atlanta Center for Clinical Research is an independent, multi-therapeutic outpatient clinical research site in Roswell, Georgia that conducts Phase II, III, and IV trials for pharmaceutical sponsors and CROs.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

All Other Outpatient Care Centers (621498)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Clinical Trial Site Operations & Study Coordination (HLAGACAE)

akta.pro secondary industries

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC), Clinical Development (Phase I–III Trial Design & Execution) (HLAIALAE)

Keywords

• Clinical trial services
• Outpatient research site
• Phase II/III/IV trials
• Patient recruitment services
• Clinical research coordination

Headquarters

HQ city

Roswell

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Clinical Trial Services: ACCR generates revenue by conducting Phase II, III, and IV clinical trials for pharmaceutical companies and CROs. They are compensated for study execution, patient enrollment, data collection, and regulatory compliance services. Revenue is project-based, tied to specific trial protocols and milestones.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Atlanta Center for Clinical Research is an independent, multi-therapeutic outpatient clinical research site that conducts Phase II, III, and IV clinical trials on behalf of pharmaceutical sponsors and Contract Research Organizations. The site delivers patient recruitment, data collection, regulatory compliance, site management, QA and on-site training, and dedicated clinical research coordinator services across multiple therapeutic areas.

Product overview

Atlanta Center for Clinical Research is an independent, multi-therapeutic outpatient clinical research site offering a unified set of clinical trial services. The company conducts Phase II, III, and IV clinical trials with experienced management staff, dedicated clinical research coordinators (CRCs), and regulatory specialists. Supporting services include site management, QA and on-site training, clinical research site development, and recruitment services. The company operates as a single-service organization focused on providing high-quality clinical research data to pharmaceutical sponsors and CROs.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase II Clinical Trials Early-stage human clinical trials conducted with 100-300 participants to evaluate treatment effectiveness and further assess safety, performed on behalf of pharmaceutical sponsors and CROs.
• Phase III Clinical Trials Large-scale trials involving 1,000-3,000 participants to confirm effectiveness, monitor side effects, and compare investigational treatments against commonly used standard treatments.
• Phase IV Clinical Trials Post-marketing studies conducted after drug approval to delineate additional information including risks, benefits, and optimal use of an approved treatment.
• Site Management Services Comprehensive site management for clinical trials including dedicated clinical research coordinators, accurate and timely CRF completion, rapid responsive communications, and professionally developed corporate SOPs.
• Quality Assurance and On-Site Training Quality assurance and on-site training services ensuring compliance with study protocols, regulatory requirements, and ICH-GCP standards across all clinical research activities.
• Regulatory Services Dedicated regulatory specialist services for study compliance, documentation, IRB submissions, and ongoing regulatory adherence throughout the lifecycle of each clinical trial.
• Patient Recruitment Services Study-specific, site-based recruitment planning and materials designed to support high patient enrollment and retention rates for sponsor and CRO clinical trials.
• Clinical Research Site Development Development services for establishing and configuring clinical research site capabilities to meet sponsor and CRO protocol requirements across multiple therapeutic areas.

Quantifiable outcome

• 15 years of experience
• +2 more outcomes

Named customers10 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Ten partnerships are on record, tiered core.

• PfizercoreStrategic or Co-development PartnerPfizer is one of the major pharmaceutical companies in ACCR's established network. ACCR conducts clinical trials sponsored by Pfizer as an investigative research site. This partnership represents a core revenue-generating relationship for ACCR.
• TakedacoreStrategic or Co-development PartnerTakeda Pharmaceuticals is part of ACCR's network of pharmaceutical sponsors. ACCR serves as a clinical trial site for Takeda's drug development programs, conducting Phase II-IV trials.
• AmgencoreStrategic or Co-development PartnerAmgen is among the pharmaceutical sponsors in ACCR's network. ACCR conducts clinical research for Amgen's therapeutic compounds as an independent study site.
• AstraZenecacoreStrategic or Co-development PartnerAstraZeneca partners with ACCR for clinical trial execution. ACCR provides site services including patient recruitment, data collection, and regulatory compliance for AstraZeneca-sponsored studies.
• BayercoreStrategic or Co-development PartnerBayer is a pharmaceutical sponsor in ACCR's partner network. ACCR conducts clinical trials on behalf of Bayer as part of their drug development process.
• QuintilescoreStrategic or Co-development PartnerQuintiles (now IQVIA) is a major CRO that engages ACCR as a clinical trial site. ACCR provides study execution services under Quintiles-managed protocols.
• PPDcoreStrategic or Co-development PartnerPPD (Pharmaceutical Product Development) is a CRO partner of ACCR. ACCR serves as an investigative site for PPD-managed clinical trials on behalf of pharmaceutical sponsors.
• IconcoreStrategic or Co-development PartnerIcon Clinical Research engages ACCR for clinical trial site services. ACCR provides patient enrollment and data collection services for Icon-managed studies.
• ParexelcoreStrategic or Co-development PartnerParexel International is a CRO partner of ACCR. ACCR conducts clinical trials under Parexel's management as a contracted research site.
• CovancecoreStrategic or Co-development PartnerCovance is a CRO partner of ACCR. ACCR provides clinical research site services for Covance-managed pharmaceutical trials.

Scale indicators3 records

Recent moves3 records

Expansion highlights5 records

Broad incumbents

• Parexel International: Global CRO offering full clinical development services including site management. Listed as an ACCR CRO partner and representative of broad incumbent CROs whose site strategies affect independent site economics.
• ICON plc: Global CRO providing clinical trial management including site services following its PRA Health Sciences merger. Comparable as a large incumbent that both partners with and competes against independent outpatient sites like ACCR.
• IQVIA (formerly Quintiles): Largest global CRO with an integrated site network (including Synexus). A listed ACCR partner through its Quintiles brand and a dominant industry incumbent that competes with ACCR for sponsor study allocations while also serving as a customer channel.
• PPD (Pharmaceutical Product Development, part of Thermo Fisher Scientific): Major global CRO with site management and patient recruitment capabilities. Listed as an ACCR CRO partner and representative of the broad incumbent peer set that offers in-house site services alongside CRO functions.
• Medpace Holdings: Mid-to-large global CRO with therapeutic-area-focused clinical trial execution. Comparable to ACCR in serving pharmaceutical sponsors for Phase II–IV trials, though at much greater scale and with broader geographic reach.

Direct peers

• Meridian Clinical Research: Independent, multi-therapeutic outpatient clinical research site network conducting Phase II–IV trials. Closely comparable to ACCR in operating model (independent outpatient site, multi-TA, sponsor-direct engagement) but operates multiple US locations.
• Accelerated Enrollment Solutions (now part of IQVIA): Dedicated multi-therapeutic clinical trial site network focused on patient enrollment and retention. Operates in the same outpatient-site category as ACCR and competes for sponsor study placements in overlapping therapeutic areas.
• Clinedge (now part of Worldwide Clinical Trials): Clinical trial site network providing site management and patient recruitment services for sponsors and CROs. Comparable to ACCR as an outsourced outpatient research site operator serving pharmaceutical and CRO clients.
• Synexus (Synexus Clinical Research, part of IQVIA): Largest global dedicated site management organization (SMO) network, operating outpatient clinical research sites across multiple countries and therapeutic areas. Directly comparable to ACCR as a multi-therapeutic outpatient site operator, but at significantly greater scale and geographic reach.

Emerging players

• Clinipace Worldwide: Smaller CRO with site network and patient recruitment services targeting small to mid-sized biopharma. Comparable to ACCR in serving as a more accessible partner for sponsors seeking alternatives to mega-CROs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/atlccr

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Atlanta Center for Clinical Research